ADC Therapeutics to Participate in Cantor Global Healthcare Conference
ADC Therapeutics SA announced its CEO, Ameet Mallik, will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York.
LAUSANNE, Switzerland – ADC Therapeutics SA (NYSE: ADCT) has announced that Chief Executive Officer Ameet Mallik will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference. The event is scheduled to take place in New York.
Mallik is slated to speak on Friday, September 11, 2026, at 9:10 a.m. Eastern Time. The discussion is expected to cover the company's strategic direction and advancements in its pipeline of antibody-drug conjugates (ADCs) for cancer treatment.
The Cantor Global Healthcare Conference brings together executives from healthcare companies, biotechnology firms, and investors. It serves as a platform for discussing industry trends, therapeutic developments, and investment opportunities.
ADC Therapeutics is focused on developing and commercializing ADCs for patients with hematological and solid tumors. The company's participation highlights its ongoing engagement with the financial and healthcare communities.